ANL
Adlai Nortye Ltd.
NASDAQ · Healthcare · Biotechnology · KY
$15.01
+1.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 31.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.50x
- Price / sales
- 49.12x
- Price / cash flow
- -16.67x
Enterprise value
- Enterprise value
- $760.5M
- EV / sales
- 38.64x
- EV / EBITDA
- -35.42x
- EV / EBIT
- -34.11x
- Market cap
- $966.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026